APYX
Apyx Medical Corp
NASDAQ · Healthcare · Medical - Devices · US
$2.42
−5.10%Sep 29, 2026, 12:00 UTC
Apyx Medical Corporation announced results from a prospective clinical study evaluating the effects of its Renuvion helium plasma radiofrequency technology on biological markers of skin quality.
Source:Aug 6, 2026, 20:05 UTC
Apyx Medical Corporation reported its financial results for the second quarter ended June 30, 2026.